☆ 4.7 Article

Risk of systemic lupus erythematosus flares according to autoantibody positivity at the time of diagnosis

SCIENTIFIC REPORTS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Rheumatology

Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

Celline C. Almeida-Brasil et al.

Summary: The risk of SLE flare was higher after HCQ tapering or discontinuation compared to HCQ maintenance, especially for patients with low educational level and prednisone use. Special attention should be paid to specific subgroups when making decisions on HCQ maintenance.

ANNALS OF THE RHEUMATIC DISEASES (2022)

添加到收藏夹

Article Immunology

Early B Cell and Plasma Cell Kinetics Upon Treatment Initiation Portend Flares in Systemic Lupus Erythematosus: A Post-Hoc Analysis of Three Phase III Clinical Trials of Belimumab

Ioannis Parodis et al.

Summary: This study found that early changes in certain B cell subsets and anti-dsDNA levels in patients with systemic lupus erythematosus upon treatment initiation may herald subsequent severe disease flares. Rapid expansion of memory B cells may signify sustained response to therapy, while no return or delayed increases in memory B cells may indicate flare development.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Rheumatology

Associations of improvement in laboratory tests with clinical outcomes in patients with active systemic lupus erythematosus: a multinational longitudinal cohort study

Kathryn Connelly et al.

Summary: This study aimed to determine the association between improvements in routinely measured laboratory tests and clinical improvement in patients with active SLE. The study found that improvements in proteinuria, albumin, hemoglobin, erythrocyte sedimentation rate, and platelets were most strongly associated with disease activity and damage protection, while improvements in serological tests were mainly associated with physician global assessment and modified SLE responder index. These findings suggest the need to revise the use of laboratory test results in SLE trial endpoints.

LANCET RHEUMATOLOGY (2022)

添加到收藏夹

Article Rheumatology

New developments in systemic lupus erythematosus

Michel W. P. Tsang-A-Sjoe et al.

Summary: Recent clinical trials in SLE patients have shown promising results, with belimumab being the first successful biologic designed for SLE. Additionally, research has revealed new pathways involved in the disease, leading to the identification of potential new therapeutics. The hope is that these advancements will lead to more personalized medicine for SLE patients in the future.

RHEUMATOLOGY (2021)

添加到收藏夹

Article Rheumatology

Risk factors for the flare of systemic lupus erythematosus and its influence on prognosis: a single-center retrospective analysis

Xiaohong Zeng et al.

Summary: Various risk factors, such as infection, thrombocytopenia, arthritis, and positive anti-nucleosome and anti-beta 2-glycoprotein I (IgG) antibodies, may contribute to the flare of SLE. Self-discontinuation of medicine maintenance therapy is the main cause of severe SLE flare, leading to a higher incidence of pulmonary hypertension.

ADVANCES IN RHEUMATOLOGY (2021)

添加到收藏夹

Article Rheumatology

Disease severity, flares and treatment patterns in adults with systemic lupus erythematosus in the UK: a real-world observational retrospective cohort analysis

Julia Langham et al.

Summary: The study in the UK found that most SLE patients experience disease flare within 2 months of diagnosis. Early treatment may help delay or reduce the severity of the first SLE flare, leading to slower disease progression, lower accrual of organ damage, and better outcomes.

RHEUMATOLOGY ADVANCES IN PRACTICE (2021)

添加到收藏夹

Article Rheumatology

Anti-Smith antibody is associated with disease activity in patients with new-onset systemic lupus erythematosus

Sung Soo Ahn et al.

RHEUMATOLOGY INTERNATIONAL (2019)

添加到收藏夹

Article Rheumatology

Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort

M. F. Ugarte-Gil et al.

LUPUS (2018)

添加到收藏夹

Article Rheumatology

Repeat Testing of Antibodies and Complements in Systemic Lupus Erythematosus: When Is It Enough?

Thomas C. Raissi et al.

JOURNAL OF RHEUMATOLOGY (2018)

添加到收藏夹

Article Rheumatology

Antibodies to extractable nuclear antigens (ENAS) in systemic lupus erythematosus patients: correlations with clinical manifestations and disease activity

Y. Emad et al.

REUMATISMO (2018)

添加到收藏夹

Review Rheumatology

The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus

Myles J. Lewis et al.

RHEUMATOLOGY (2017)

添加到收藏夹

Article Rheumatology

Antinuclear antibody testing - misunderstood or misbegotten?

David S. Pisetsky

NATURE REVIEWS RHEUMATOLOGY (2017)

添加到收藏夹

Article Rheumatology

Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort

Noerni Gyori et al.

LUPUS SCIENCE & MEDICINE (2017)

添加到收藏夹

Review Rheumatology

Anti-DNA antibodies - quintessential biomarkers of SLE

David S. Pisetsky

NATURE REVIEWS RHEUMATOLOGY (2016)

添加到收藏夹

Article Rheumatology

Clinical associations of anti-Smith antibodies in PROFILE: a multi-ethnic lupus cohort

Mariangeli Arroyo-Avila et al.

CLINICAL RHEUMATOLOGY (2015)

添加到收藏夹

Article Rheumatology

The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort

Manuel F. Ugarte-Gil et al.

ANNALS OF THE RHEUMATIC DISEASES (2015)

添加到收藏夹

Article Rheumatology

A surge in anti-dsDNA titer predicts a severe lupus flare within six months

N. Pan et al.

LUPUS (2014)

添加到收藏夹

Article Rheumatology

Identification of clinical predictors of flare in systemic lupus erythematosus patients: a 24-month prospective cohort study

Luis Ines et al.

RHEUMATOLOGY (2014)

添加到收藏夹

Article Rheumatology

Baseline Predictors of Systemic Lupus Erythematosus Flares: Data From the Combined Placebo Groups in the Phase III Belimumab Trials

Michelle A. Petri et al.

ARTHRITIS AND RHEUMATISM (2013)

添加到收藏夹

Article Rheumatology

Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus

Michelle Petri et al.

ARTHRITIS AND RHEUMATISM (2012)

添加到收藏夹

Article Rheumatology

Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosus

Fan Lian et al.

RHEUMATOLOGY INTERNATIONAL (2012)

添加到收藏夹

Article Rheumatology

International consensus for a definition of disease flare in lupus

N. Ruperto et al.

LUPUS (2011)

添加到收藏夹

Review Medicine, General & Internal

MECHANISMS OF DISEASE Systemic Lupus Erythematosus

George C. Tsokos

NEW ENGLAND JOURNAL OF MEDICINE (2011)

添加到收藏夹

Review Rheumatology

Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus

Guillermo J. Pons-Estel et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)

添加到收藏夹

Article Rheumatology

Prevalence of Flare and Influence of Demographic and Serologic Factors on Flare Risk in Systemic Lupus Erythematosus: A Prospective Study

Michelle Petri et al.

JOURNAL OF RHEUMATOLOGY (2009)

添加到收藏夹

Article Rheumatology

Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus

S. Agarwal et al.

LUPUS (2009)

添加到收藏夹

Review Rheumatology

Fifty years of anti-ds DNA antibodies: are we approaching journey's end?

D. A. Isenberg et al.

RHEUMATOLOGY (2007)

添加到收藏夹

Article Rheumatology

Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus

MD Linnik et al.

ARTHRITIS AND RHEUMATISM (2005)

添加到收藏夹

Article Rheumatology

Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus

IEA Hoffman et al.

ANNALS OF THE RHEUMATIC DISEASES (2004)

添加到收藏夹

Article Medicine, General & Internal

Development of autoantibodies before the clinical onset of systemic lupus erythematosus

MR Arbuckle et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

添加到收藏夹

Article Rheumatology

Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis

P Alba et al.

ANNALS OF THE RHEUMATIC DISEASES (2003)

添加到收藏夹

Article Rheumatology

Definition and treatment of lupus flares measured by the BILAG index

C Gordon et al.

RHEUMATOLOGY (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.